SLNO
Soleno Therapeutics, Inc.NASDAQHealthcare$39.49+32.31%ClosedMarket Cap: $2.12B
As of 2026-04-06
Insider Statistics (Q1 2026)
Purchases
18
Sales
0
Buy/Sell Ratio
0.00
Total Bought
$0.00
Total Sold
$0.00
Recent Insider Trades
| Filing Date | Name | Type | Action | Shares | Price | Shares After |
|---|---|---|---|---|---|---|
| Tue Mar 31 | Manning Meredith | officer: Chief Commercial Officer | Sell | 558 | $31.72 | 64,507 |
| Tue Mar 31 | Manning Meredith | officer: Chief Commercial Officer | Sell | 2,100 | $31.04 | 65,065 |
| Tue Mar 31 | Manning Meredith | officer: Chief Commercial Officer | Sell | 4,864 | $30.04 | 67,165 |
| Tue Mar 31 | Huang Michael F. | officer: Sr. VP of Clinical Development | Sell | 488 | $31.72 | 39,823 |
| Tue Mar 31 | Huang Michael F. | officer: Sr. VP of Clinical Development | Sell | 1,838 | $31.04 | 40,311 |
| Tue Mar 31 | Huang Michael F. | officer: Sr. VP of Clinical Development | Sell | 4,256 | $30.04 | 42,149 |
| Wed Mar 04 | Fulk Jennifer | officer: CHIEF FINANCIAL OFFICER | Sell | 67,660 | $39.06 | 67,660 |
| Wed Mar 04 | Fulk Jennifer | officer: CHIEF FINANCIAL OFFICER | Sell | 39,200 | $0.00 | 39,200 |
| Wed Mar 04 | Fulk Jennifer | Sell | 0 | $0.00 | 0 | |
| Fri Jan 23 | Mackaness James H | officer: CHIEF FINANCIAL OFFICER | Sell | 28,600 | $0.00 | 131,763 |
| Fri Jan 23 | Manning Meredith | officer: Chief Commercial Officer | Sell | 32,800 | $43.65 | 32,800 |
| Fri Jan 23 | Manning Meredith | officer: Chief Commercial Officer | Sell | 28,600 | $0.00 | 72,029 |
| Fri Jan 23 | Norrett Kevin | officer: Chief Business Officer | Sell | 4,000 | $43.65 | 4,000 |
| Fri Jan 23 | Norrett Kevin | officer: Chief Business Officer | Sell | 3,500 | $0.00 | 17,786 |
| Fri Jan 23 | Yen Kristen | officer: SEE REMARKS | Sell | 11,900 | $43.65 | 11,900 |